Protein Purification and Isolation Sales

Protein Purification and Isolation Sales Market Outlook

The global Protein Purification and Isolation market is poised to reach approximately $5.7 billion by 2035, with a compound annual growth rate (CAGR) of around 9.1% during the forecast period from 2025 to 2035. The growth of this market is driven by the increasing demand for biopharmaceuticals, advancements in proteomics research, and the rising prevalence of chronic diseases that necessitate precise diagnostic tools. Enhanced research funding in biotechnology and pharmaceuticals is also bolstering the demand for purification technologies. Moreover, the growing prevalence of genetic disorders and the need for targeted therapies underscore the importance of efficient protein purification methods in drug development processes. As a result, the market is expected to witness substantial growth across various segments and regions, ultimately transforming the landscape of biopharmaceutical manufacturing and research.

Growth Factor of the Market

The protein purification and isolation market is experiencing significant growth due to several pivotal factors. One of the primary drivers is the steady increase in investment in research and development within the biotechnology and pharmaceutical sectors. This investment is primarily aimed at developing novel therapeutics and vaccines, which often necessitate complex protein purification processes. Furthermore, the rise in personalized medicine, coupled with an increasing focus on precision medicine, is fostering a demand for advanced purification techniques to ensure that biologics are safe and effective. The global trend towards automation in laboratory processes also plays a critical role, streamlining workflows and enhancing productivity, thus accelerating the adoption of sophisticated purification systems. Additionally, stringent regulatory requirements regarding the quality and safety of biopharmaceutical products are pushing companies to invest in more efficient purification technologies. Collectively, these growth factors indicate a bright future for the protein purification and isolation market, as stakeholders recognize the value of high-quality purified proteins in research and therapeutic applications.

Key Highlights of the Market

• The global market is projected to reach $5.7 billion by 2035.
• The CAGR for the market is estimated at 9.1% from 2025 to 2035.
• Rising demand for biopharmaceuticals is a significant growth driver.
• Automation trends in laboratories are enhancing the efficiency of protein purification.
• Stringent regulatory frameworks are necessitating advanced purification technologies.

By Product Type

Chromatography Systems:

Chromatography systems are pivotal in the protein purification and isolation market due to their versatility and effectiveness. They are widely used for separating biomolecules based on their size, charge, or affinity to specific ligands. The chromatography segment includes various techniques such as affinity chromatography, ion exchange chromatography, and others. These systems are favored for their ability to achieve high purity levels and are essential in biopharmaceutical manufacturing processes. As the demand for high-quality therapeutic proteins increases, chromatography systems are experiencing significant growth, particularly in regions with advanced biotechnology research capabilities. The continuous advancements in chromatography technologies are expected to further enhance their application in protein purification, thereby driving market growth.

Electrophoresis Systems:

Electrophoresis systems play an essential role in protein purification by enabling the separation of proteins based on their size and charge. This technique is particularly valuable in the analysis of complex protein mixtures and is extensively employed in proteomics research and disease diagnosis. The growth of the electrophoresis systems segment is fueled by the increasing focus on understanding protein functions and interactions, which are crucial in drug discovery and development. Additionally, the advancements in gel and capillary electrophoresis technologies are expected to enhance the efficiency and resolution of protein separation, driving their adoption in both academic and industrial laboratories. As the demand for proteomic analysis continues to grow, the electrophoresis systems segment is likely to see sustained expansion in the coming years.

Western Blotting Systems:

Western blotting systems are integral to the protein purification landscape, specifically for the detection and quantification of specific proteins in a complex mixture. This technique is widely used in various applications, including disease diagnosis, drug discovery, and proteomics research. The growth of this segment is primarily driven by the increasing demand for accurate and reliable protein analysis methods. With advancements in western blotting technologies, such as improved detection methods and enhanced sensitivity, researchers are now able to generate more precise data, leading to greater adoption of these systems. As the emphasis on protein characterization and validation increases in both research and clinical settings, the western blotting systems segment is expected to witness significant growth in the coming years.

Centrifugation Systems:

Centrifugation systems are critical in protein purification, primarily used to separate proteins from cell debris, nucleic acids, and other contaminants. The efficiency and speed of centrifugation techniques make them indispensable in various applications, including biotechnology and pharmaceuticals. The segment's growth is largely attributed to the increasing demand for high-throughput purification processes, which are essential for large-scale production of therapeutic proteins. Additionally, the advancements in centrifugation technologies, such as the development of high-speed and ultracentrifuges, are enhancing the efficiency of protein purification workflows. As the global biopharmaceutical industry continues to expand, centrifugation systems are expected to play a pivotal role in meeting the demands for purified proteins.

Filtration Systems:

Filtration systems are essential in the protein purification process, particularly for removing impurities and concentrating proteins. This method is widely used in various applications such as bioprocessing, where the purification of biomolecules is critical. The filtration segment is experiencing growth due to the increasing need for efficient and cost-effective purification technologies in the biopharmaceutical industry. Technological advancements in membrane filtration, such as the introduction of single-use systems and disposable filters, are further enhancing the adoption of filtration techniques. As companies seek to streamline their production processes while maintaining high-quality standards, the filtration systems segment is poised for significant expansion in the global market.

By Application

Drug Discovery:

The drug discovery application segment is a significant contributor to the protein purification and isolation market, as it encompasses the processes involved in the identification and development of novel therapeutics. Protein purification is an essential step in drug discovery, enabling researchers to isolate target proteins for high-throughput screening and validation. The increasing investment in biotechnology and pharmaceutical research is driving the growth of this application segment, with a focus on developing targeted therapies for various diseases. Moreover, the rising prevalence of chronic diseases and genetic disorders is further propelling the demand for effective drug discovery processes, thus positively impacting the protein purification market.

Disease Diagnosis:

The application of protein purification in disease diagnosis is a critical aspect of the healthcare industry. Purified proteins are used in various diagnostic assays, including immunoassays and biomarker identification, enabling accurate disease detection and monitoring. The growing emphasis on early and precise diagnosis of diseases is driving the demand for efficient protein purification methods. Additionally, advancements in diagnostic technologies, along with an increasing prevalence of infectious and chronic diseases, are further boosting the growth of this application segment. As healthcare providers emphasize the importance of accurate diagnostic tools, the protein purification market is likely to see continued growth in disease diagnosis applications.

Proteomics Research:

Proteomics research is an emerging field that focuses on the large-scale study of proteins, their structures, functions, and interactions. Protein purification is a fundamental step in proteomics workflows, enabling researchers to analyze complex protein mixtures and gain insights into biological processes. The rapid advancements in proteomics technologies and an increasing emphasis on understanding protein dynamics are driving the growth of this application segment. With the rising interest in personalized medicine and targeted therapies, proteomics research is becoming increasingly relevant, thus propelling the demand for effective protein purification solutions. As the field of proteomics continues to evolve, the protein purification market is expected to witness substantial growth in this area.

Biotechnology:

The biotechnology application segment is a significant driver of the protein purification and isolation market. The biotechnology industry relies heavily on purified proteins for the development of biopharmaceuticals, diagnostic kits, and other therapeutic products. The rapid growth of the biotechnology sector, fueled by innovations in genetic engineering and synthetic biology, is increasing the demand for efficient protein purification technologies. Additionally, with the rising number of biotech startups and research initiatives focused on developing novel therapies, the protein purification market is well-positioned to benefit from the growth of this dynamic industry. As biotechnology continues to advance, the need for high-quality purified proteins will remain a critical factor in its success.

Others:

The 'Others' application segment encompasses various niches within the protein purification and isolation market that do not fall under the major categories mentioned above. This segment includes applications in food and beverage industries, environmental testing, and academic research, where protein purification plays a role in quality control, safety testing, and experimental validation. As industries increasingly recognize the importance of protein analysis and characterization, the demand for purification technologies across these diverse applications is expected to grow. Furthermore, the expansion of research initiatives in these areas highlights the potential for continued growth in the protein purification market, driven by the need for high-quality, purified proteins.

By Distribution Channel

Direct Sales:

Direct sales channels are crucial for the protein purification and isolation market, enabling manufacturers to sell their products directly to end-users, such as laboratories and research institutions. This distribution model allows companies to establish strong relationships with their customers, providing personalized support and better understanding of their specific needs. Additionally, direct sales often lead to higher profit margins for manufacturers, as they eliminate intermediaries. As the demand for custom solutions and tailored support grows within the scientific community, direct sales channels are expected to expand, offering significant opportunities for protein purification companies to enhance their market presence.

Distributor Sales:

Distributor sales play an essential role in the protein purification market by providing manufacturers with access to a broader customer base through established distribution networks. Distributors often have extensive experience and knowledge of local markets, which can be advantageous for manufacturers looking to expand their reach. This channel is particularly beneficial for smaller companies and startups that may lack the resources to establish a direct sales force. The growth of the distributor sales segment is attributed to the increasing demand for protein purification products across various industries, including pharmaceuticals, biotechnology, and academic research. As the market continues to expand, distributor sales are likely to remain a vital component of the protein purification landscape.

Online Retail:

The online retail segment is rapidly emerging as a significant distribution channel in the protein purification market, driven by the growing trend of e-commerce and the increasing reliance on digital platforms for purchasing scientific products. Online retail offers numerous advantages, including convenience, accessibility, and the ability to compare products easily. Customers can access a wide range of purification products from various manufacturers at their fingertips, facilitating informed purchasing decisions. Additionally, the rise of online marketplaces and dedicated scientific e-commerce platforms is further enhancing the visibility of protein purification products. As laboratories and research institutions increasingly opt for online purchasing, this segment is expected to witness substantial growth in the coming years.

By Technique

Affinity Chromatography:

Affinity chromatography is one of the most widely used techniques in protein purification due to its specificity and efficiency. This technique relies on the specific interactions between a target protein and a particular ligand immobilized on a solid support. Affinity chromatography is valued for its ability to achieve high purity levels in a single step, making it a preferred method for purifying monoclonal antibodies and other therapeutic proteins. The growing demand for biologics and biosimilars is driving the expansion of this segment, as researchers increasingly rely on affinity chromatography to isolate and purify proteins for clinical applications. As advancements in ligand design and immobilization techniques emerge, the affinity chromatography segment is expected to continue its growth trajectory.

Ion Exchange Chromatography:

Ion exchange chromatography is a powerful technique for protein purification based on the net charge of biomolecules. This method allows for the separation of proteins according to their charge properties, enabling researchers to achieve high-resolution purification of complex protein mixtures. The growth of the ion exchange chromatography segment is driven by the increasing demand for high-purity proteins in biopharmaceutical production and research applications. Additionally, advancements in resin technology and optimized buffer systems are enhancing the efficiency and effectiveness of ion exchange processes. As the biopharmaceutical industry continues to expand, the application of ion exchange chromatography in protein purification is expected to grow significantly.

Size Exclusion Chromatography:

Size exclusion chromatography (SEC) is a valuable technique for protein purification that separates biomolecules based on their size. This method is particularly useful for desalting and concentrating proteins, as well as for the separation of oligomers and aggregates from monomers. The SEC segment is experiencing growth due to its application in various fields, including biopharmaceuticals, where purity and structural integrity are critical. As the demand for characterizing proteins and analyzing their structural properties increases, size exclusion chromatography is becoming an essential tool in laboratories. The ongoing advancements in SEC materials and systems are further enhancing its applicability, contributing to the segment's expansion.

High-Performance Liquid Chromatography:

High-performance liquid chromatography (HPLC) is a sophisticated technique used in protein purification and analysis that offers high resolution and reproducibility. HPLC is particularly valuable in the pharmaceutical industry for the quality control and characterization of therapeutic proteins and peptides. The demand for HPLC systems is driven by the increasing emphasis on regulatory compliance and the need for precise analytical methods in biopharmaceutical development. With the ongoing innovations in HPLC technology, including the development of ultra-high-performance liquid chromatography (UHPLC) systems, the efficiency and speed of protein purification processes are significantly enhanced. As regulatory pressures grow, the HPLC segment is expected to see robust growth, further solidifying its position in the protein purification market.

By Region

The regional analysis of the protein purification and isolation market reveals significant variations in market size and growth potential across different areas. North America holds a prominent position in this market, with a projected share of approximately 40% by 2035. The high concentration of biotechnology and pharmaceutical companies, along with substantial research funding and advanced healthcare infrastructure, are key factors driving this growth. Additionally, the region is home to numerous leading companies specializing in protein purification technologies, further solidifying its dominance. North America is projected to grow at a CAGR of 8.9% during the forecast period, emphasizing its vital role in the global market.

Europe also represents a significant share of the protein purification and isolation market, accounting for approximately 30% of the total market value. The growth in this region is driven by a strong emphasis on research and development, particularly within the life sciences sector. Countries such as Germany, the United Kingdom, and France are at the forefront of biopharmaceutical research, contributing to the robust demand for efficient protein purification technologies. The region is witnessing a CAGR of 8.5%, indicating a healthy growth trajectory fueled by increasing investments in biotechnology and healthcare. Meanwhile, the Asia Pacific region is expected to emerge as a key growth driver in the coming years, with rapid advancements in biotechnology research and a growing number of biopharmaceutical companies.

Opportunities

The protein purification and isolation market is ripe with opportunities, particularly in the biopharmaceutical sector. As the demand for biologics and biosimilars continues to rise, there is a pressing need for efficient purification technologies that can deliver high-quality products. Companies that invest in innovation and technological advancements will likely capture significant market share, as they develop purification systems that meet the evolving needs of the industry. Moreover, the increasing trend towards personalized medicine opens up new avenues for customized purification solutions tailored to specific therapeutic applications. As stakeholders recognize the importance of high-purity proteins in ensuring the safety and efficacy of treatments, the market is poised for substantial growth driven by these emerging opportunities.

Furthermore, collaborations and partnerships between academic institutions and industry players present another avenue for growth in the protein purification market. Research institutions are continuously seeking innovative purification methods to support their studies, and by partnering with established companies, they can access cutting-edge technologies and expertise. This collaborative approach can lead to the development of novel purification techniques that enhance productivity and efficiency. Additionally, the rise in funding for scientific research in both private and public sectors will further bolster the demand for protein purification products. As the landscape of protein research evolves, the market is expected to benefit from these collaborative efforts and increased research initiatives, presenting a wealth of opportunities for companies involved in protein purification and isolation.

Threats

Despite the promising outlook for the protein purification and isolation market, it faces several threats that could impact growth. One of the primary concerns is the increasing competition among manufacturers, which can lead to price wars and reduced profit margins. As more companies enter the market with innovative purification technologies, established players may find it challenging to maintain their market share and pricing strategies. Additionally, the rapid pace of technological advancements means that companies must continually invest in research and development to stay ahead of the competition. Failure to innovate could result in a loss of relevance in a rapidly changing market landscape. Furthermore, economic uncertainties and fluctuations in funding for research and development can pose challenges, as budget constraints may limit the ability of institutions and companies to invest in advanced purification technologies.

Another significant threat to the protein purification market is the stringent regulatory environment governing biopharmaceutical products. Regulatory agencies demand high standards of quality and safety, which can create barriers to market entry for new players. Companies must navigate complex regulatory processes to ensure compliance, which can be time-consuming and costly. Additionally, any changes in regulations or increased scrutiny of manufacturing processes can impact the market landscape, necessitating ongoing adjustments and investments. Moreover, the COVID-19 pandemic highlighted vulnerabilities in global supply chains and demonstrated the need for robust contingency plans. Disruptions in the supply chain can affect the availability of critical components required for protein purification systems, potentially hindering market growth.

Competitor Outlook

• Thermo Fisher Scientific Inc.
• GE Healthcare Life Sciences
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• Agilent Technologies, Inc.
• Pall Corporation
• Waters Corporation
• MilliporeSigma (Merck Group)
• PerkinElmer, Inc.
• F. Hoffmann-La Roche AG
• Haplogen GmbH
• Repligen Corporation
• Qiagen N.V.
• Eppendorf AG
• Promega Corporation

The competitive landscape of the protein purification and isolation market is characterized by a diverse range of players, including large multinational corporations, mid-sized companies, and specialized biotech firms. These companies are engaged in continuous research and development efforts to innovate and enhance their product offerings. The competition is particularly intense in the chromatography and filtration segments, where advancements in technology can significantly impact efficiency and effectiveness. Companies are also focusing on strategic collaborations and partnerships to expand their market presence and leverage complementary expertise. For instance, collaborations between academic institutions and industry players are driving innovation, leading to the development of novel purification techniques and technologies.

Leading companies like Thermo Fisher Scientific, GE Healthcare, and Bio-Rad Laboratories are at the forefront of the protein purification market, leveraging their extensive portfolios and established reputations. Thermo Fisher, for example, offers a wide range of chromatography, filtration, and electrophoresis products, catering to various segments within the protein purification landscape. Similarly, GE Healthcare Life Sciences is known for its innovative bioprocess solutions, which are essential for biopharmaceutical manufacturing. These industry giants are continually investing in research and development to stay ahead of competitors and meet the growing demands of the market.

Additionally, companies such as Merck KGaA and Agilent Technologies are focusing on expanding their product lines and enhancing their purification technologies. Merck, for example, has made significant strides in chromatography and filtration systems, while Agilent is known for its advanced analytical solutions, including HPLC systems. The commitment to innovation and quality positions these companies favorably in the competitive landscape. As the protein purification and isolation market continues to evolve, collaboration, innovation, and strategic investments will be vital for companies looking to secure a competitive edge and drive growth in this burgeoning market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Merck KGaA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Qiagen N.V.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Eppendorf AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Haplogen GmbH
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Pall Corporation
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 PerkinElmer, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Waters Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Promega Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Repligen Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 F. Hoffmann-La Roche AG
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Agilent Technologies, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Bio-Rad Laboratories, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 GE Healthcare Life Sciences
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 MilliporeSigma (Merck Group)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Thermo Fisher Scientific Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Protein Purification and Isolation Sales Market, By Technique
    • 6.1.1 Affinity Chromatography
    • 6.1.2 Ion Exchange Chromatography
    • 6.1.3 Size Exclusion Chromatography
    • 6.1.4 High-Performance Liquid Chromatography
    • 6.1.5 Others
  • 6.2 Protein Purification and Isolation Sales Market, By Application
    • 6.2.1 Drug Discovery
    • 6.2.2 Disease Diagnosis
    • 6.2.3 Proteomics Research
    • 6.2.4 Biotechnology
    • 6.2.5 Others
  • 6.3 Protein Purification and Isolation Sales Market, By Product Type
    • 6.3.1 Chromatography Systems
    • 6.3.2 Electrophoresis Systems
    • 6.3.3 Western Blotting Systems
    • 6.3.4 Centrifugation Systems
    • 6.3.5 Filtration Systems
  • 6.4 Protein Purification and Isolation Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales
    • 6.4.3 Online Retail

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Protein Purification and Isolation Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Protein Purification and Isolation Sales market is categorized based on

By Product Type

• Chromatography Systems
• Electrophoresis Systems
• Western Blotting Systems
• Centrifugation Systems
• Filtration Systems

By Application

• Drug Discovery
• Disease Diagnosis
• Proteomics Research
• Biotechnology
• Others

By Distribution Channel

• Direct Sales
• Distributor Sales
• Online Retail

By Technique

• Affinity Chromatography
• Ion Exchange Chromatography
• Size Exclusion Chromatography
• High-Performance Liquid Chromatography
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific Inc.
• GE Healthcare Life Sciences
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• Agilent Technologies, Inc.
• Pall Corporation
• Waters Corporation
• MilliporeSigma (Merck Group)
• PerkinElmer, Inc.
• F. Hoffmann-La Roche AG
• Haplogen GmbH
• Repligen Corporation
• Qiagen N.V.
• Eppendorf AG
• Promega Corporation